These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 1538909

  • 1. [Oncogenes and mitotic signal transduction].
    Tavitian A.
    Pathol Biol (Paris); 1992 Nov; 39(9):860. PubMed ID: 1538909
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structure/function relationships of ras and guanosine triphosphatase-activating protein.
    Gibbs JB, Schaber MD, Garsky VM, Vogel US, Scolnick EM, Dixon RA, Marshall MS.
    Soc Gen Physiol Ser; 1990 Nov; 45():77-85. PubMed ID: 2198666
    [No Abstract] [Full Text] [Related]

  • 4. The interplay between ras oncogenes and tumor suppressor genes in experimental carcinogenesis.
    Balmain A, Brown K, Bremner R.
    Immunol Ser; 1990 Nov; 51():75-88. PubMed ID: 2128916
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ras regulatory interactions: novel targets for anti-cancer intervention?
    Prendergast GC, Gibbs JB.
    Bioessays; 1994 Mar; 16(3):187-91. PubMed ID: 8166672
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y, Gutierrez L, Wrathall LS, Lu YY, Blair DG, Clanton DJ, Hwang YW, Shih TY.
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP.
    Bazenet CE, Kazlauskas A.
    Oncogene; 1994 Feb; 9(2):517-25. PubMed ID: 8290262
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activators and effectors of ras p21 proteins.
    McCormick F.
    Curr Opin Genet Dev; 1994 Feb; 4(1):71-6. PubMed ID: 8193543
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
    Bortner DM, Langer SJ, Ostrowski MC.
    Crit Rev Oncog; 1993 Feb; 4(2):137-60. PubMed ID: 8380545
    [Abstract] [Full Text] [Related]

  • 18. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
    Weiss B, Bollag G, Shannon K.
    Am J Med Genet; 1999 Mar 26; 89(1):14-22. PubMed ID: 10469432
    [Abstract] [Full Text] [Related]

  • 19. The transmembrane domain of the large subunit of HSV-2 ribonucleotide reductase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation.
    Smith CC, Luo JH, Hunter JC, Ordonez JV, Aurelian L.
    Virology; 1994 May 01; 200(2):598-612. PubMed ID: 8178446
    [Abstract] [Full Text] [Related]

  • 20. Amino acid 61 is a determinant of sensitivity of rap proteins to the ras GTPase activating protein.
    Hart PA, Marshall CJ.
    Oncogene; 1990 Jul 01; 5(7):1099-101. PubMed ID: 2115644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.